APIs for research and impurities
Active Pharmaceutical Ingredients (APIs) are the substances in drugs responsible for their therapeutic effects. In this section, you will find a wide variety of APIs intended for research use. These compounds are essential for the development, testing, and validation of new pharmaceutical formulations. CymitQuimica offers high-quality APIs to support research in drug discovery and development.
Subcategories of "APIs for research and impurities"
- Alkaloids
- Aminoacids and derivatives
- Anthraquinones and derivatives
- Benzimidazole and Imidazole Derivatives
- Benzodiazepine Derivatives
- Carbohydrates and glycoconjugates
- Esters and Derivatives
- Fatty Acids and Lypidic Derivatives
- Flavonoids and Polyphenols
- Free Radicals and Oxidant/Reducing Agents
- Ketones and derivatives
- Natural and semi-synthetic antibiotics
- Nitriles and Cyano Derivatives
- Nitrosamines and Derivatives
- Nucleosides and Nucleotides
- Organic Phosphates and Phosphonates
- Organic Sulphonates and Sulphates
- Organometallics
- Others
- Peptides and Proteins
- Polymers and Derivatives
- Purines and Pyrimidine Derivatives
- Quinazoline and Quinoline Derivatives
- Quinones and Derivatives
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)
- Steroids and Derivatives
- Sulfonamides and Derivatives
- Terpenoids and Derivatives
- Thiazolidinediones and Thiopyrans
- β-Adrenergic Compounds
Show 22 more subcategories
Products of "APIs for research and impurities"
Sort by
Carisoprodol EP Impurity C
CAS:Formula:C7H16O2Color and Shape:White To Off-White SolidMolecular weight:132.20Dihydro-Naphthalene Impurity 2
CAS:Formula:C13H16OColor and Shape:Pale Yellow LiquidMolecular weight:188.276H-Pyrimido[1,6-b]pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-
CAS:Formula:C19H9Cl2F2N3OSPurity:98%Color and Shape:SolidMolecular weight:436.26214-Isopropoxy-N-(2-methylquinolin-8-yl)benzamide
CAS:Formula:C20H20N2O2Purity:98%Color and Shape:SolidMolecular weight:320.385Ambroxol Impurity 14 (Cycloimine Impurity)
CAS:Formula:C14H16Br2N2OColor and Shape:White To Off-White SolidMolecular weight:388.10Ivermectin EP impurity E
Ivermectin EP impurity E is an impurity of Ivermectin. It is a natural metabolite of Ivermectin that was first identified in 1979. It is not currently used as a drug, but it has been studied for its potential to treat Parkinson's disease and other neurological disorders. Ivermectin EP impurity E has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis. Ivermectin EP impurity E is a natural metabolite of Ivermectin which was first identified in 1979. It is not currently used as a drug, but it has been studied for its potential to treat Parkinson's disease and other neurological disorders. Ivermectin EP impurity E has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandins synthesis.Formula:C49H76O14Purity:Min. 95%Molecular weight:889.12 g/molTirzepatide Impurity 15 Di-Trifluoroacetate (D-Phe 6 )
Formula:C225H348N48O68·2C2HF3O2Molecular weight:4813.53 2*114.02Levomepromazine EP Impurity B-13C-d3 (Levomepromazine S-Oxide-13C-d3)
CAS:Formula:C1813CH18D3N2O2SMolecular weight:348.48Benzoic acid, 4-chlorophenyl ester
CAS:Formula:C13H9ClO2Purity:97%Color and Shape:SolidMolecular weight:232.6624
![6H-Pyrimido[1,6-b]pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA002K7Y.webp&w=3840&q=75)
